These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17315603)

  • 21. Soluble endothelial cell-selective adhesion molecule and incident cardiovascular events in a multiethnic population.
    Ren HY; Khera A; de Lemos JA; Ayers CR; Rohatgi A
    Am Heart J; 2017 Sep; 191():55-61. PubMed ID: 28888270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers of vascular injury and endothelial dysfunction after recent glucose intolerance in pregnancy.
    Bajaj HS; Ye C; Hanley AJ; Sermer M; Zinman B; Retnakaran R
    Diab Vasc Dis Res; 2018 Sep; 15(5):449-457. PubMed ID: 29871496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of extract of Gingko biloba on soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in patients with early diabetic nephropathy].
    Li XS; Fu XJ; Lang XJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 May; 27(5):412-4. PubMed ID: 17650793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated levels of plasma von Willebrand factor and the risk of macro- and microvascular disease in type 2 diabetic patients with microalbuminuria.
    Gaede P; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2001 Oct; 16(10):2028-33. PubMed ID: 11572892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial cell-selective adhesion molecule in diabetic nephropathy.
    Kacso IM; Kacso G
    Eur J Clin Invest; 2012 Nov; 42(11):1227-34. PubMed ID: 22957687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adhesion molecules in type 2 diabetes].
    Sokup A
    Przegl Lek; 2005; 62(4):234-7. PubMed ID: 16229242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction.
    Hope SA; Meredith IT
    Intern Med J; 2003; 33(9-10):450-62. PubMed ID: 14511199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.
    de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
    Circulation; 2004 Aug; 110(8):921-7. PubMed ID: 15302780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.
    Lim SC; Caballero AE; Smakowski P; LoGerfo FW; Horton ES; Veves A
    Diabetes Care; 1999 Nov; 22(11):1865-70. PubMed ID: 10546021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma soluble intercellular adhesion molecule 1 levels are increased in type 2 diabetic patients with nephropathy.
    Güler S; Cakir B; Demirbas B; Yönem A; Odabasi E; Onde U; Aykut O; Gürsoy G
    Horm Res; 2002; 58(2):67-70. PubMed ID: 12207164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy.
    Alkhalaf A; Kleefstra N; Groenier KH; Bilo HJ; Gans RO; Heeringa P; Scheijen JL; Schalkwijk CG; Navis GJ; Bakker SJ
    PLoS One; 2012; 7(7):e40427. PubMed ID: 22792314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Soluble-phase adhesion molecules as biohumoral markers of vascular activation in vivo].
    Gianetti J; Vaghetti M; Petronio S; Mariani M; De Caterina R
    Cardiologia; 1999 Feb; 44(2):125-36. PubMed ID: 10208049
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiovascular disease in patients with diabetic nephropathy.
    Aso Y
    Curr Mol Med; 2008 Sep; 8(6):533-43. PubMed ID: 18781960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between the levels of circulating adhesion molecules and atherosclerosis in hypertensive type-2 diabetic patients.
    Rubio-Guerra AF; Vargas-Robles H; Serrano AM; Vargas-Ayala G; Rodriguez-Lopez L; Escalante-Acosta BA
    Clin Exp Hypertens; 2010; 32(5):308-10. PubMed ID: 20662732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification.
    Silvestro A; Brevetti G; Schiano V; Scopacasa F; Chiariello M
    Thromb Haemost; 2005 Mar; 93(3):559-63. PubMed ID: 15735810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
    Meigs JB; Hu FB; Rifai N; Manson JE
    JAMA; 2004 Apr; 291(16):1978-86. PubMed ID: 15113816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism-based modeling of the effect of a novel inhibitor of vascular adhesion protein-1 on albuminuria and renal function markers in patients with diabetic kidney disease.
    Hoefman S; Snelder N; van Noort M; Garcia-Hernandez A; Onkels H; Larsson TE; Bergmann KR
    J Pharmacokinet Pharmacodyn; 2021 Feb; 48(1):21-38. PubMed ID: 32929612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation.
    Rovira-Llopis S; Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; Andújar I; Jover A; Pantoja J; Pallardo LM; Bañuls C; Victor VM
    Cell Physiol Biochem; 2018; 50(3):1005-1014. PubMed ID: 30355913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.